Novelix Pharmaceuticals Ltd
Novelix Pharmaceuticals Ltd - 536565 - Announcement under Regulation 30 (LODR)-Change in Directorate
01 / The disclosure
What the company shared
Attached
A question for your research
Check the role, effective date, stated reason and succession arrangements.
The evidence
Read the source excerpts
01Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Members the Company at 32nd Annual General Meeting held on 30th September, 2026, has approved the appointment of Mr. Gnana Prakash Gattu (DIN:00517921) as Whole Time Director of the Company for a period for 5 years w.e.f.
Page 1
02HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, in respect of aforesaid appointment is given in ‘Annexure I’ to this letter.
Page 1
03appointment The Shareholders has approved the appointment of Mr. Gnana Prakash Gattu as Whole Time director of the company in 32nd Annual General meeting held on 30th September 2026.
Page 2
04Term of Appointment Effective date of Appointment 29th August, 2026
Page 2
05Name of the listed entities in which resigning director holds directorship including category of directorship and membership of committee, if any Nil 4.
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 46e905ea-0acc-4a67-82b6-3c0ea3c5b1f0
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- c69e80c3a23970e5725cf79efdeeae6dad59fc25b050499bdb5dd3e54cab2e65